SlideServe
Télécharger Obtenir Pro
Menu
Accueil Pro
Préférences
ApparenceLight Aide et commentaires
© SlideServe · v2026

GAP573 – Novel Peptide Modulator of Cell Communication

amber-bowen avatar
amber-bowen
9 diapositives · 172 Views · Nov 07, 2014

Discover GAP573, a peptide that accelerates wound healing, reduces inflammation, and promotes blood vessel formation. Find out more about this innovative technology and its potential applications.

#gap573 – novel peptide modulator of cell communication #gap573 – novel peptide modulator of cell communication ppt #powerpoint #presentation
GAP573 – Novel Peptide Modulator of Cell Communication - slide 1
01 / 9GAP573 – Novel Peptide Modulator of Cell Communication
1 / 17

Télécharger la présentation

GAP573 – Novel Peptide Modulator of Cell Communication
Une image / un lien ci-dessous est fourni (tel quel) pour télécharger la présentation

Politique de téléchargement : le contenu du site vous est fourni TEL QUEL pour votre information et votre usage personnel ; il ne peut être vendu, concédé sous licence ni partagé sur d’autres sites sans l’accord de son auteur.Le contenu vous est fourni TEL QUEL, pour votre information et votre usage personnel uniquement. Téléchargez la présentation en cliquant sur ce lien. Lors du téléchargement, si vous ne parvenez pas à télécharger une présentation, l’éditeur a peut-être supprimé le fichier de son serveur.Pendant le téléchargement, si vous ne parvenez pas à obtenir une présentation, le fichier a peut-être été supprimé par l’éditeur.

F I N

Plus de contenu associé

Transcription de la présentation

  1. GAP573 – Novel Peptide Modulator of Cell Communication Presenter: Dr Keryn Johnson Senior Research Scientist Industrial Research Limited, NZ k.johnson@irl.cri.nz Contact: Dr Duncan Veal, Commercialisation Manager, Meat and Livestock Australia dveal@mla.com.au Dr Keryn Johnson k.johnson@irl.cri.nz Mobile: +64 (0) 212941174

  2. Disclaimer Care is taken to ensure the accuracy of the information contained in this publication. However MLA and IRL cannot accept responsibility for the accuracy or completeness of the information or opinions contained in the publication. You should make your own enquiries before making decisions concerning your interests. MLA and IRL accepts no liability for any losses incurred if you rely solely on this publication concerning your interests. Dr Keryn Johnson k.johnson@irl.cri.nz Mobile: +64 (0) 212941174

  3. Technology – GAP573 Sheep Lens Technology| Our Solution | Development Status | Market Size | Competitive Edge| Summary Dr Keryn Johnson k.johnson@irl.cri.nz Mobile: +64 (0) 212941174 Discovered in animal lenses MOA - Cell communication Low likelihood of adverse reactions Small peptide enter cells Simple to manufacture short peptide

  4. Application 1 - Wound Healing Diabetic Food Ulcer • 200,000 Australians have foot ulcers • 45,000 Australians have lost a limb • 1000 Australians die each year from complications. • Growing problem • Aging population • Increase in prevalence of chronic disease • Spiralling health care costs Unmet Market Need | Our Solution | Development Status | Market Size | Competitive Edge| Summary Dr Keryn Johnson k.johnson@irl.cri.nz Mobile: +64 (0) 212941174

  5. The Solution Inhibition of Gap junction communication GAP573 in alginate gel GAP573 proposed binding to ZO Unmet Market Need | The Solution | Development Status | Market Size | Competitive Edge| Summary Dr Keryn Johnson k.johnson@irl.cri.nz Mobile: +64 (0) 212941174

  6. Inflammatory cell staining CD68 -macrophage Pig wound healing pilot study Stimulation of blood vessel formation Rat wound healing closure rate Gap573 Control GAP573 Preclinical Studies Unmet Market Need | Our Solution | Development Status | Market Size | Competitive Edge| Summary Dr Keryn Johnson k.johnson@irl.cri.nz Mobile: +64 (0) 212941174

  7. Market Size [1] Drug-device Combinations: The Global Market Report Code: PHM045B Published: January 2010 BCC research Unmet Market Need | Our Solution | Development Status | Market Size | Competitive Edge| Summary Dr Keryn Johnson k.johnson@irl.cri.nz Mobile: +64 (0) 212941174

  8. Competitive Edge Unmet Market Need | Our Solution | Development Status | Market Size | Competitive Edge| Summary Dr Keryn Johnson k.johnson@irl.cri.nz Mobile: +64 (0) 212941174

  9. GAP573 Summary • Strategic partner to commercialise GAP573 a modulator of gap junction communication • Accelerates wound healing • Reduces inflammation • Promotes blood vessel formation (angiogenesis) • Reduces scaring • Patented technology (2 families) • Significant market need Unmet Market Need | Our Solution | Development Status | Market Size | Competitive Edge| Summary Dr Keryn Johnson k.johnson@irl.cri.nz Mobile: +64 (0) 212941174